Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 160 | 172 | 153 | 178 | 179 |
| Income taxes - deferred | N/A | N/A | 25 | 1 | 8 |
| Accounts receivable | 52 | 247 | 27 | -141 | 99 |
| Accounts payable and accrued liabilities | 146 | 74 | 199 | 239 | -537 |
| Other Working Capital | 298 | 447 | 476 | 832 | -912 |
| Other Operating Activity | -871 | -1,754 | -2,078 | -2,069 | -1,346 |
| Operating Cash Flow | $-215 | $-813 | $-1,197 | $-960 | $-2,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -3 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -50 | 0 | 0 |
| Investing Cash Flow | $0 | $0 | $-53 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7 | -21 | 10 | -31 | -819 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 4,183 |
| Other Financing Activity | 0 | 765 | 40 | 1,350 | 2 |
| Financing Cash Flow | $-7 | $744 | $50 | $1,319 | $3,366 |
| Exchange Rate Effect | 0 | 0 | 0 | 43 | -48 |
| Beginning Cash Position | 395 | 464 | 1,665 | 1,263 | 453 |
| End Cash Position | 173 | 395 | 464 | 1,665 | 1,263 |
| Net Cash Flow | $-222 | $-70 | $-1,201 | $359 | $858 |
| Free Cash Flow | |||||
| Operating Cash Flow | -215 | -813 | -1,197 | -960 | -2,509 |
| Free Cash Flow | -215 | -813 | -1,197 | -960 | -2,509 |